TG Therapeutics Inc. (TGTX)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 0 |
| Ownership rank: | -- |
| % of all portfolios: | 0% |
| History | Portfolio Manager | Activity ▼ | Share change | % change to portfolio | |
| Q1 2023 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Sell 100.00% | 4,318,700 | 1.24 | |
| Q4 2022 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Reduce 43.93% | 3,383,170 | 0.97 | |
| Q3 2022 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Add 14.14% | 954,321 | 0.13 | |
| Q2 2022 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Add 1.05% | 69,823 | 0.01 | |
| Q1 2022 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Add 10.65% | 642,851 | 0.11 | |
| Q4 2021 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Add 83.07% | 2,738,424 | 0.63 | |
| Q3 2021 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Add 16.85% | 475,372 | 0.17 | |
| Q2 2021 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Reduce 5.05% | 150,057 | 0.05 | |
| Q1 2021 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Reduce 7.21% | 230,925 | 0.10 | |
| Q4 2020 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Reduce 27.10% | 1,190,135 | 0.99 | |
| Q3 2020 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Add 3277.60% | 4,262,157 | 2.12 | |
| Q2 2020 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Buy | 130,039 | 0.05 | |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.